Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
| Total | Transactions | Amount |
| Buys | 0 | $0 |
| Sells | 12 | $2,634,534 |
| Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
| 18 Jan 2024 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Jan 2024 | Sale | 18,000 | 10.93 | 196,740 | D |
| 19 Dec 2023 19:22 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Dec 2023 | Sale | 18,000 | 9.6 | 172,800 | D |
| 17 Nov 2023 17:52 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Nov 2023 | Sale | 18,000 | 6.51 | 117,180 | D |
| 18 Oct 2023 17:34 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 16 Oct 2023 | Sale | 18,000 | 6.3 | 113,400 | D |
| 19 Sep 2023 17:50 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Sep 2023 | Sale | 18,000 | 8.66 | 155,880 | D |
| 17 Aug 2023 18:39 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 15 Aug 2023 | Sale | 18,000 | 9.25 | 166,500 | D |
| 27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 26 Jul 2023 | Sale | 20,000 | 14.41 | 288,200 | D |
| 27 Jul 2023 18:31 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 25 Jul 2023 | Sale | 20,000 | 14.3 | 286,000 | D |
| 19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 18 Jul 2023 | Sale | 30,000 | 13.74 | 412,200 | D |
| 19 Jul 2023 19:01 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 17 Jul 2023 | Sale | 30,000 | 11.72 | 351,600 | D |
| 05 Jun 2023 18:29 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 02 Jun 2023 | Sale | 17,865 | 8.93 | 159,534 | D |
| 05 Jun 2023 18:29 | RXRX | RECURSION PHARMACEUTICALS Inc | VIRANI SHAFIQUE | Chief Business Officer | 01 Jun 2023 | Sale | 25,000 | 8.58 | 214,500 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)